These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38521518)

  • 1. Effects of haemodiafiltration or haemofiltration compared with haemodialysis on prognosis in patients with end-stage renal disease: protocol an updated systematic review and meta-analysis of randomised trials with trial sequential analysis.
    Zhang F; Liao J; Bai Y; Zhang Z; Huang L; Zhong Y
    BMJ Open; 2024 Mar; 14(3):e080541. PubMed ID: 38521518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effectiveness of exercise training on elderly patients who require haemodialysis: study protocol for a systematic review and meta-analysis.
    Matsuzawa R; Hoshi K; Yoneki K; Matsunaga A
    BMJ Open; 2016 May; 6(5):e010990. PubMed ID: 27231003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home versus in-centre haemodialysis for people with kidney failure.
    Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of automated versus continuous ambulatory peritoneal dialysis for end-stage kidney disease: protocol of a systematic review and meta-analysis.
    Shi X; Du H; Zhang Z; Zhou Y
    BMJ Open; 2022 Nov; 12(11):e065795. PubMed ID: 36323481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
    Lu W; Jiang GR;
    BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in arterial stiffness indices during a single haemodialysis session in end-stage renal disease population: a systematic review and meta-analysis protocol.
    Fortier C; Obeid H; Paré M; Garneau CA; Sidibé A; Boutouyrie P; Agharazii M
    BMJ Open; 2021 Sep; 11(9):e045912. PubMed ID: 34475148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-volume haemofiltration for sepsis in adults.
    Borthwick EM; Hill CJ; Rabindranath KS; Maxwell AP; McAuley DF; Blackwood B
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD008075. PubMed ID: 28141912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review and meta-analysis protocol.
    Barrett PM; McCarthy FP; Kublickiene K; Evans M; Cormican S; Judge C; Perry IJ; Kublickas M; Stenvinkel P; Khashan AS
    BMJ Open; 2019 May; 9(5):e027180. PubMed ID: 31061049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eversion technique versus conventional endarterectomy with patch angioplasty in carotid surgery: protocol for a systematic review with meta-analyses and trial sequential analysis of randomised clinical trials.
    Marsman MS; Wetterslev J; Vriens PWHE; Bleys RLAW; Jahrome AK; Moll FL; Keus F; Koning GG
    BMJ Open; 2020 Apr; 10(4):e030503. PubMed ID: 32312723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol.
    Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ
    BMJ Open; 2019 Jan; 9(1):e023736. PubMed ID: 30782714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects with semaglutide: a protocol for a systematic review with meta-analysis and trial sequential analysis.
    Sillassen CDB; Kamp CB; Petersen JJ; Faltermeier P; Siddiqui F; Grand J; Dominguez H; Frølich A; Gæde PH; Gluud C; Mathiesen O; Jakobsen J
    BMJ Open; 2024 Jun; 14(6):e084190. PubMed ID: 38908837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
    Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.